About Biolabs Group
Biolabs Group is a Healthcare company based in India. It operates as a distribution of pharmaceutical excipients, laboratory chemicals, and equipment in India. It operates in the Healthcare and Chemicals & Materials sectors. Biolabs Group offers products and services including Pharmaceutical Excipients and Laboratory Chemicals. Its focus areas include Pharmaceuticals, Chemical Distribution, Excipients and Reagents and Industrial Supplies. Its legal entity in India is Biolabs and Life Sciences LLP (AAL-0387).
Company details
Biolabs Group is identified as a leading distributor of pharmaceutical excipients, laboratory consumables, and equipment, partnering with global brands to supply high-purity products to industries like pharma and biotech. A research center is maintained for innovation in biotechnology and environmental science, supported by NABL accreditation for quality assurance. Operations are established across multiple Indian locations, facilitating reliable delivery and supporting scientific advancements, while values such as teamwork and customer focus are emphasized in business practices.
- Headquarters India
- SectorsHealthcareChemicals & Materials
- Email••••••••
- Phone•••• ••••
- Legal Name Biolabs And Life Sciences Llp
- Date of Incorporation 03 Nov, 2017
- Jurisdiction Chennai, Tamil Nadu, India
Associated legal entities of Biolabs Group
Biolabs Group operates through Biolabs And Life Sciences Llp (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Biolabs And Life Sciences Llp CIN AAL-0387 | Active | 03 Nov 2017 | Chennai, Tamil Nadu | – | – | 2 | View details |
Products & Services of Biolabs Group
Biolabs Group offers a comprehensive portfolio of products and services, including Pharmaceutical Excipients and Laboratory Chemicals.
Pharmaceutical excipients are supplied for enhancing drug stability and bioavailability in manufacturing processes
Laboratory chemicals are provided for research and quality control purposes across various scientific applications
Board of directors of Biolabs And Life Sciences Llp (Biolabs Group)
Biolabs And Life Sciences Llp is the primary company behind Biolabs Group. The board of Biolabs And Life Sciences Llp currently have 2 directors; the longest-serving is Raghavachari Govindan, appointed in 2017.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Raghavachari Govindan DIN 07921182 | Designated Partner | 03 Nov 2017 | 8 yrs 11 mo | Biolabs And Life Sciences Llp |
| Jeyashri Govindan DIN 07917037 | Designated Partner | 03 Nov 2017 | 8 yrs 11 mo | Biolabs And Life Sciences Llp |
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as Biolabs Group (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 213.52 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Biolabs Group
Biolabs Group is headquartered in India.
Biolabs Group is identified as a leading distributor of pharmaceutical excipients, laboratory consumables, and equipment, partnering with global brands to supply high-purity products to industries like pharma and biotech. A research center is maintained for innovation in biotechnology and environmental science, supported by NABL accreditation for quality assurance. Operations are established across multiple Indian locations, facilitating reliable delivery and supporting scientific advancements, while values such as teamwork and customer focus are emphasized in business practices.
Biolabs Group offers Pharmaceutical Excipients and Laboratory Chemicals.
Biolabs Group operates through Biolabs And Life Sciences Llp.
The legal entities of Biolabs Group currently have 2 directors, including Raghavachari Govindan, Jeyashri Govindan.